Y Kawano1, J Kawada1, Y Kamiya1, M Suzuki1, Y Torii1, H Kimura2, Y Ito1. 1. Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. 2. Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Abstract
OBJECTIVE: Cytomegalovirus (CMV) is the most common cause of congenital infection and can cause neurodevelopmental disabilities, although a majority of patients are asymptomatic. Biomarkers associated with disease severity would be desirable to distinguish asymptomatic from mildly symptomatic patients who may benefit from antiviral treatment. MicroRNAs (miRNAs) are noncoding RNAs that may have the potential to serve as biomarkers. STUDY DESIGN: Thirteen infants with congenital CMV infection were enrolled, and plasma levels of 11 human- and 3 CMV-encoded miRNAs were quantitated by real-time PCR. Plasma levels of miRNAs and their associations with clinical features were evaluated. RESULTS: The levels of miR-183-5p and miR-210-3p were significantly higher in patients with congenital CMV infection than in control infants, whereas no significant associations between levels of miRNAs and clinical features of congenital CMV infection were observed. CONCLUSION: Plasma miRNAs could be associated with the pathogenesis of congenital CMV infection and could be used as disease biomarkers.
OBJECTIVE: Cytomegalovirus (CMV) is the most common cause of congenital infection and can cause neurodevelopmental disabilities, although a majority of patients are asymptomatic. Biomarkers associated with disease severity would be desirable to distinguish asymptomatic from mildly symptomatic patients who may benefit from antiviral treatment. MicroRNAs (miRNAs) are noncoding RNAs that may have the potential to serve as biomarkers. STUDY DESIGN: Thirteen infants with congenital CMV infection were enrolled, and plasma levels of 11 human- and 3 CMV-encoded miRNAs were quantitated by real-time PCR. Plasma levels of miRNAs and their associations with clinical features were evaluated. RESULTS: The levels of miR-183-5p and miR-210-3p were significantly higher in patients with congenital CMV infection than in control infants, whereas no significant associations between levels of miRNAs and clinical features of congenital CMV infection were observed. CONCLUSION: Plasma miRNAs could be associated with the pathogenesis of congenital CMV infection and could be used as disease biomarkers.
Authors: Diwakar Santhakumar; Thorsten Forster; Nouf N Laqtom; Rennos Fragkoudis; Paul Dickinson; Cei Abreu-Goodger; Sergei A Manakov; Nila Roy Choudhury; Samantha J Griffiths; Annaleen Vermeulen; Anton J Enright; Bernadette Dutia; Alain Kohl; Peter Ghazal; Amy H Buck Journal: Proc Natl Acad Sci U S A Date: 2010-07-19 Impact factor: 11.205
Authors: Matthew A Maccani; Michele Avissar-Whiting; Carolyn E Banister; Bethany McGonnigal; James F Padbury; Carmen J Marsit Journal: Epigenetics Date: 2010-10-01 Impact factor: 4.528
Authors: L F Lisboa; A Egli; D O'Shea; A Åsberg; A Hartmann; H Rollag; X L Pang; D L Tyrrell; D Kumar; A Humar Journal: Am J Transplant Date: 2015-04-01 Impact factor: 8.086
Authors: Harry L A Janssen; Hendrik W Reesink; Eric J Lawitz; Stefan Zeuzem; Maribel Rodriguez-Torres; Keyur Patel; Adriaan J van der Meer; Amy K Patick; Alice Chen; Yi Zhou; Robert Persson; Barney D King; Sakari Kauppinen; Arthur A Levin; Michael R Hodges Journal: N Engl J Med Date: 2013-03-27 Impact factor: 91.245
Authors: Alberto Talaya; Estela Giménez; María Jesús Pascual; Beatriz Gago; José Luis Piñana; Juan Carlos Hernández-Boluda; Lourdes Vázquez; Magdalena García; David Serrano; Marta Hernández; Eliseo Albert; Carlos Solano; David Navarro Journal: Med Microbiol Immunol Date: 2019-09-03 Impact factor: 3.402